Cargando…

Benchmarking the Cost-Effectiveness of Interventions Delaying Diabetes: A Simulation Study Based on NAVIGATOR Data

OBJECTIVE: To estimate using the UK Prospective Diabetes Study Outcomes Model Version 2 (UKPDS-OM2) the impact of delaying type 2 diabetes onset on costs and quality-adjusted life expectancy using trial participants who developed diabetes in the NAVIGATOR (Nateglinide And Valsartan in Impaired Gluco...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leal, Jose, Reed, Shelby D., Patel, Rishi, Rivero-Arias, Oliver, Li, Yanhong, Schulman, Kevin A., Califf, Robert M., Holman, Rury R., Gray, Alastair M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2020
Materias:	Epidemiology/Health Services Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7510029/ https://www.ncbi.nlm.nih.gov/pubmed/32796009 http://dx.doi.org/10.2337/dc20-0717

Ejemplares similares

Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial
por: Becker, Frauke, et al.
Publicado: (2022)

Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study
por: Donnelly, Louise A., et al.
Publicado: (2020)

Can peer support be cost saving? An economic evaluation of RAPSID: a randomized controlled trial of peer support in diabetes compared to usual care alone in East of England communities
por: Wingate, La’Marcus, et al.
Publicado: (2017)

Accurately Reflecting Uncertainty When Using Patient-Level Simulation Models to Extrapolate Clinical Trial Data
por: Dakin, Helen A., et al.
Publicado: (2020)

Economic Evaluation of Factorial Trials: Cost-Utility Analysis of the Atorvastatin in Factorial With Omega EE90 Risk Reduction in Diabetes 2 × 2 × 2 Factorial Trial of Atorvastatin, Omega-3 Fish Oil, and Action Planning
por: Dakin, Helen A., et al.
Publicado: (2020)

Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): A longitudinal analysis of a randomized, double‐blind, placebo‐controlled trial
por: Leal, José, et al.
Publicado: (2022)

Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom
por: Rivero-Arias, Oliver, et al.
Publicado: (2010)

Temporal Validation of the UKPDS Outcomes Model Using 10-Year Posttrial Monitoring Data
por: Leal, Jose, et al.
Publicado: (2013)

Cost and Cost-effectiveness of Large-scale Screening for Type 1 Diabetes in Colorado
por: McQueen, R. Brett, et al.
Publicado: (2020)

National disability insurance scheme access: What evidence do you need to provide for psychosocial disability?
por: Shelby-James, Tania, et al.
Publicado: (2023)

Rationing of total knee replacement: a cost-effectiveness analysis on a large trial data set
por: Dakin, Helen, et al.
Publicado: (2012)

Prospective relationships between body weight and physical activity: an observational analysis from the NAVIGATOR study
por: Preiss, David, et al.
Publicado: (2015)

Evaluations of statistical methods for outlier detection when benchmarking in clinical registries: a systematic review
por: Hansen, Jessy, et al.
Publicado: (2023)

What do we know about managing Dupuytren’s disease cost-effectively?
por: Dritsaki, Melina, et al.
Publicado: (2018)

Nationally Representative Medical Costs of Diabetes by Time Since Diagnosis
por: Trogdon, Justin G., et al.
Publicado: (2008)

Smoking is associated with pessimistic and avoidant beliefs about cancer: results from the International Cancer Benchmarking Partnership
por: Quaife, S L, et al.
Publicado: (2015)

Newly incident cannabis use in the United States, 2002–2011: a regional and state level benchmark
por: Leinweber, Jacob P., et al.
Publicado: (2017)

Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP)
por: Menon, Usha, et al.
Publicado: (2019)

Effect of periodontal treatment on diabetes-related healthcare costs: a retrospective study
por: Smits, Kirsten P J, et al.
Publicado: (2020)

Cost-Effectiveness of MODY Genetic Testing: Translating Genomic Advances Into Practical Health Applications
por: Naylor, Rochelle N., et al.
Publicado: (2014)

Direct costs in impaired glucose regulation: results from the population-based Heinz Nixdorf Recall study
por: Bächle, C, et al.
Publicado: (2016)

Evaluation of AUSDRISK as a screening tool for lifestyle modification programs: international implications for policy and cost-effectiveness
por: Malo, Jonathan A, et al.
Publicado: (2015)

Health Care Use and Costs Associated With Use of a Health Club Membership Benefit in Older Adults with Diabetes
por: Nguyen, Huong Q., et al.
Publicado: (2008)

Cost analysis of the flash monitoring system (FreeStyle Libre 2) in adults with type 1 diabetes mellitus
por: Oyagüez, Itziar, et al.
Publicado: (2020)

Performance and costs of multiple screening strategies for type 2 diabetes: two population-based studies in Shanghai, China
por: Li, Yanyun, et al.
Publicado: (2020)

Assessing the pre-implementation context for financial navigation in rural and non-rural oncology clinics
por: Petermann, Victoria M., et al.
Publicado: (2023)

Early treatment revisions by addition or switch for type 2 diabetes: impact on glycemic control, diabetic complications, and healthcare costs
por: Schwab, Phil, et al.
Publicado: (2016)

Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: a comparison with general population, 2015
por: Jodar, Esteban, et al.
Publicado: (2020)

Effectiveness, treatment durability, and treatment costs of canagliflozin and glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes in the USA
por: Singhal, Mukul, et al.
Publicado: (2019)

Elevated incidence rates of diabetes in Peru: report from PERUDIAB, a national urban population-based longitudinal study
por: Seclen, Segundo Nicolas, et al.
Publicado: (2017)

Impact of an Intensive Lifestyle Intervention on Use and Cost of Medical Services Among Overweight and Obese Adults With Type 2 Diabetes: The Action for Health in Diabetes
por: Espeland, Mark A., et al.
Publicado: (2014)

Prevalence of diabetes and impaired fasting glucose in Peru: report from PERUDIAB, a national urban population-based longitudinal study
por: Seclen, Segundo N, et al.
Publicado: (2015)

Cost-effectiveness of a self-management and comprehensive training intervention in patients with type 2 diabetes up to 5 years of diagnosis in a specialized hospital in Mexico City
por: Hernández-Jiménez, Sergio, et al.
Publicado: (2021)

Low-to-moderate alcohol intake and breast cancer risk in Chinese women
por: Zhang, M, et al.
Publicado: (2011)

Population-Level Impact and Cost-effectiveness of Continuous Glucose Monitoring and Intermittently Scanned Continuous Glucose Monitoring Technologies for Adults With Type 1 Diabetes in Canada: A Modeling Study
por: Rotondi, Michael A., et al.
Publicado: (2022)

Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP)
por: Weller, David, et al.
Publicado: (2018)

Editorial: Opportunity costs in health care: cost-effectiveness thresholds and beyond
por: Sampson, Chris, et al.
Publicado: (2023)

‘Turning the tide’ on hyperglycemia in pregnancy: insights from multiscale dynamic simulation modeling
por: Freebairn, Louise, et al.
Publicado: (2020)

Open-source computational simulation of moth-inspired navigation algorithm: A benchmark framework
por: Golov, Yiftach, et al.
Publicado: (2021)

Risk factors for delay in symptomatic presentation: a survey of cancer patients
por: Forbes, L J L, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2jipc6053qbvb8k7rgu0l7n50t